NCT03315962Completed
Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
Source: ClinicalTrials.gov · Last updated 18 Jun 2025
Brief summary (registry, in English)
The overall objective of this study is to determine if a multi-component implementation intervention (SPIRIT) and additional leadership and management training that targets District Health Officers (DHOs) can increase IPT initiation among HIV-infected persons, as compared to country standard practices, in a cluster randomized trial in Uganda.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 163 (actual)
- First submitted
- 26 Sept 2017
- Start date
- 15 Nov 2017
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- University of California, San Francisco
- Diseases
- Tuberculosis, HIV
- NCT number
- NCT03315962
What you commit to
- Study type: Interventional
- Participants enrolled: 163
- From 15 Nov 2017 to the primary completion date, 30 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planned departure from position as DHO or TB District Supervisor prior to randomization.
Other
- DHOs from Kampala and Wakiso districts, Uganda.
Who the study is looking for
- District Health Officer or TB District Supervisor (or other DHO-appointed TB focal person) in Uganda.
- By definition, the DHO or TB District Supervisor are all ≥18 years of age.
Criteria the registry did not label
- AIM 1 - Spirit Intervention:
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Infectious Diseases Research Collaboration Coordinator of this site? Confirm its status | Kampala | Uganda | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.